CHELSEA HOLMES: Open Payments
NPI 1467175760 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,519 in 67 payments from 28 companies in 2025. Trend: 2023 $28 · 2024 $36 · 2025 $1,519
Food & beverage: $1,332Education: $187
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 7 | $202 |
| Janssen Biotech, Inc. | 8 | $149 |
| Novartis Pharmaceuticals Corporation | 5 | $107 |
| SEAGEN INC. | 1 | $88 |
| Geron Corporation | 4 | $85 |
| Agios Pharmaceuticals, Inc. | 3 | $82 |
| Telix Pharmaceuticals | 2 | $77 |
| Merck Sharp & Dohme LLC | 4 | $67 |
| AstraZeneca Pharmaceuticals LP | 3 | $65 |
| Astellas Pharma US Inc | 3 | $56 |
Products named: RYTELO, PYRUKYND, Enhertu, ILLUCCIX, JAKAFI, RYBREVANT, TALVEY, SCEMBLIX.
Industry payments across FL — which companies pay providers there.
